All In MedTech

Device Trial Radar · NCT06318130

Comparison of Pacing Lead Design on Left Bundle Branch Pacing Outcomes: The LEAD_LBBP Randomized Clinical Trial

Comparison of Pacing Lead Design on Left Bundle Branch Pacing Outcomes

Last checked: Nov 20, 2026Latest source record: Jun 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 210 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

210

Planned (sponsor's estimate)

Start

Jan 1, 2023

Primary completion

Oct 19, 2025

Study completion Oct 19, 2025

Sponsor

Lead sponsor
National University Hospital, SingaporeAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 19, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 21 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This trial seeks to evaluate the performance of the extendable helix, stylet-driven pacing lead (SDL) compared to the fixed helix, lumenless pacing lead (LLL) during left bundle branch pacing (LBBP), with respect to enduring left bundle branch capture on follow-up, incidence of acute lead failure, pacing characteristics including QRS duration, pacing thresholds, R-wave amplitudes and lead impedance, and finally, safety profile during LBBP implantation. These data will guide future lead selection during LBBP implantation in achieving improved procedural success and optimal lead performance.

Conditions

  • Pacemaker DDD

Interventions

  • Fixed helix, lumenless pacing lead.Device

    Patients will be randomised to the fixed helix, lumenless pacing lead design during LBBP implantation.

  • Extendable helix, stylet-driven pacing lead.Device

    Patients will be randomised to the extendable helix, stylet-driven pacing lead design during LBBP implantation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of loss of left bundle branch captureTime frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National University Heart Centre Singapore

    Singapore, Singapore

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.